MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PNT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

POINT Biopharma Global (PNT) Ownership - Who owns POINT Biopharma Global?

POINT Biopharma Global Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
4850 West 78th Street
Phone
+1 647 812-2417
Employees
129
Web
https://www.pointbiopharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.47B
P/E Ratio
12.55
Total Cash
339.16M
Projected Growth
N/A
Total Debt
10.66M
Revenue
243.69M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.18
Total Debt/Equity
N/A
Revenue/Share
2.27 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PNT
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
4850 West 78th Street
Phone
+1 647 812-2417
Employees
129
Web
https://www.pointbiopharma.com